Fig. 4From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancerInhibition of tumor cell proliferation by anti-HFG mAb in a xenograft model. Use of anti-HFG mAb effectively inhibits growth of DLD-1 cells a but not proliferation of COLO 205 cells (b). Dose-dependent inhibitory effects of anti-HFG mAb are demonstrated in COLO 201 cells (c, d)Back to article page